img

Global PD-L1 Inhibitors Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global PD-L1 Inhibitors Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

PD-L1 inhibitors are a group of checkpoint inhibitor anticancer drugs
PD-L1 Inhibitors report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global PD-L1 Inhibitors market is projected to reach US$ 11170 million in 2029, increasing from US$ 8139 million in 2022, with the CAGR of 4.7% during the period of 2024 to 2029. Demand from Retail Pharmacy and Hospital Pharmacy are the major drivers for the industry.
The PD-1 and PD-L1 Inhibitor market is driven by the increasing demand for advanced immunotherapy options in oncology. PD-1 and PD-L1 inhibitors are revolutionary treatments that block specific proteins, enhancing the immune system's ability to recognize and attack cancer cells. The growing prevalence of various cancers, coupled with the need for targeted therapies that offer improved efficacy and fewer side effects compared to traditional treatments, contributes to market growth. Additionally, the expanding list of approved indications for these inhibitors, such as melanoma, lung cancer, and more, further propels adoption. However, challenges include managing potential immune-related adverse events and identifying patients who are most likely to respond to these treatments. Navigating the complex landscape of combination therapies and addressing access and affordability barriers for a broader patient population are ongoing concerns. The market's success relies on continuous research to optimize treatment regimens and identify biomarkers for patient selection, comprehensive patient education about the potential benefits and risks, and collaborations between pharmaceutical companies, healthcare providers, and research institutions to advance cancer treatment while addressing the evolving challenges associated with PD-1 and PD-L1 inhibitor therapy.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global PD-L1 Inhibitors market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Roche
AstraZeneca
Merck KGaA
Segment by Type
TECENTRIQ
Imfinzi
Bavencio

Segment by Application


Retail Pharmacy
Hospital Pharmacy
Other

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the PD-L1 Inhibitors market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of PD-L1 Inhibitors, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the PD-L1 Inhibitors industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of PD-L1 Inhibitors in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, PD-L1 Inhibitors introduction, etc. PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of PD-L1 Inhibitors market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 PD-L1 Inhibitors Market Overview
1.1 PD-L1 Inhibitors Product Overview
1.2 PD-L1 Inhibitors Market Segment by Type
1.2.1 TECENTRIQ
1.2.2 Imfinzi
1.2.3 Bavencio
1.3 Global PD-L1 Inhibitors Market Size by Type
1.3.1 Global PD-L1 Inhibitors Market Size Overview by Type (2018-2029)
1.3.2 Global PD-L1 Inhibitors Historic Market Size Review by Type (2018-2024)
1.3.3 Global PD-L1 Inhibitors Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America PD-L1 Inhibitors Sales Breakdown by Type (2018-2024)
1.4.2 Europe PD-L1 Inhibitors Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific PD-L1 Inhibitors Sales Breakdown by Type (2018-2024)
1.4.4 Latin America PD-L1 Inhibitors Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa PD-L1 Inhibitors Sales Breakdown by Type (2018-2024)
2 Global PD-L1 Inhibitors Market Competition by Company
2.1 Global Top Players by PD-L1 Inhibitors Sales (2018-2024)
2.2 Global Top Players by PD-L1 Inhibitors Revenue (2018-2024)
2.3 Global Top Players by PD-L1 Inhibitors Price (2018-2024)
2.4 Global Top Manufacturers PD-L1 Inhibitors Manufacturing Base Distribution, Sales Area, Product Type
2.5 PD-L1 Inhibitors Market Competitive Situation and Trends
2.5.1 PD-L1 Inhibitors Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by PD-L1 Inhibitors Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PD-L1 Inhibitors as of 2022)
2.7 Date of Key Manufacturers Enter into PD-L1 Inhibitors Market
2.8 Key Manufacturers PD-L1 Inhibitors Product Offered
2.9 Mergers & Acquisitions, Expansion
3 PD-L1 Inhibitors Status and Outlook by Region
3.1 Global PD-L1 Inhibitors Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global PD-L1 Inhibitors Historic Market Size by Region
3.2.1 Global PD-L1 Inhibitors Sales in Volume by Region (2018-2024)
3.2.2 Global PD-L1 Inhibitors Sales in Value by Region (2018-2024)
3.2.3 Global PD-L1 Inhibitors Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global PD-L1 Inhibitors Forecasted Market Size by Region
3.3.1 Global PD-L1 Inhibitors Sales in Volume by Region (2024-2029)
3.3.2 Global PD-L1 Inhibitors Sales in Value by Region (2024-2029)
3.3.3 Global PD-L1 Inhibitors Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global PD-L1 Inhibitors by Application
4.1 PD-L1 Inhibitors Market Segment by Application
4.1.1 Retail Pharmacy
4.1.2 Hospital Pharmacy
4.1.3 Other
4.2 Global PD-L1 Inhibitors Market Size by Application
4.2.1 Global PD-L1 Inhibitors Market Size Overview by Application (2018-2029)
4.2.2 Global PD-L1 Inhibitors Historic Market Size Review by Application (2018-2024)
4.2.3 Global PD-L1 Inhibitors Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America PD-L1 Inhibitors Sales Breakdown by Application (2018-2024)
4.3.2 Europe PD-L1 Inhibitors Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific PD-L1 Inhibitors Sales Breakdown by Application (2018-2024)
4.3.4 Latin America PD-L1 Inhibitors Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa PD-L1 Inhibitors Sales Breakdown by Application (2018-2024)
5 North America PD-L1 Inhibitors by Country
5.1 North America PD-L1 Inhibitors Historic Market Size by Country
5.1.1 North America PD-L1 Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America PD-L1 Inhibitors Sales in Volume by Country (2018-2024)
5.1.3 North America PD-L1 Inhibitors Sales in Value by Country (2018-2024)
5.2 North America PD-L1 Inhibitors Forecasted Market Size by Country
5.2.1 North America PD-L1 Inhibitors Sales in Volume by Country (2024-2029)
5.2.2 North America PD-L1 Inhibitors Sales in Value by Country (2024-2029)
6 Europe PD-L1 Inhibitors by Country
6.1 Europe PD-L1 Inhibitors Historic Market Size by Country
6.1.1 Europe PD-L1 Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe PD-L1 Inhibitors Sales in Volume by Country (2018-2024)
6.1.3 Europe PD-L1 Inhibitors Sales in Value by Country (2018-2024)
6.2 Europe PD-L1 Inhibitors Forecasted Market Size by Country
6.2.1 Europe PD-L1 Inhibitors Sales in Volume by Country (2024-2029)
6.2.2 Europe PD-L1 Inhibitors Sales in Value by Country (2024-2029)
7 Asia-Pacific PD-L1 Inhibitors by Region
7.1 Asia-Pacific PD-L1 Inhibitors Historic Market Size by Region
7.1.1 Asia-Pacific PD-L1 Inhibitors Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific PD-L1 Inhibitors Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific PD-L1 Inhibitors Sales in Value by Region (2018-2024)
7.2 Asia-Pacific PD-L1 Inhibitors Forecasted Market Size by Region
7.2.1 Asia-Pacific PD-L1 Inhibitors Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific PD-L1 Inhibitors Sales in Value by Region (2024-2029)
8 Latin America PD-L1 Inhibitors by Country
8.1 Latin America PD-L1 Inhibitors Historic Market Size by Country
8.1.1 Latin America PD-L1 Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America PD-L1 Inhibitors Sales in Volume by Country (2018-2024)
8.1.3 Latin America PD-L1 Inhibitors Sales in Value by Country (2018-2024)
8.2 Latin America PD-L1 Inhibitors Forecasted Market Size by Country
8.2.1 Latin America PD-L1 Inhibitors Sales in Volume by Country (2024-2029)
8.2.2 Latin America PD-L1 Inhibitors Sales in Value by Country (2024-2029)
9 Middle East and Africa PD-L1 Inhibitors by Country
9.1 Middle East and Africa PD-L1 Inhibitors Historic Market Size by Country
9.1.1 Middle East and Africa PD-L1 Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa PD-L1 Inhibitors Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa PD-L1 Inhibitors Sales in Value by Country (2018-2024)
9.2 Middle East and Africa PD-L1 Inhibitors Forecasted Market Size by Country
9.2.1 Middle East and Africa PD-L1 Inhibitors Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa PD-L1 Inhibitors Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Roche
10.1.1 Roche Company Information
10.1.2 Roche Introduction and Business Overview
10.1.3 Roche PD-L1 Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Roche PD-L1 Inhibitors Products Offered
10.1.5 Roche Recent Development
10.2 AstraZeneca
10.2.1 AstraZeneca Company Information
10.2.2 AstraZeneca Introduction and Business Overview
10.2.3 AstraZeneca PD-L1 Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.2.4 AstraZeneca PD-L1 Inhibitors Products Offered
10.2.5 AstraZeneca Recent Development
10.3 Merck KGaA
10.3.1 Merck KGaA Company Information
10.3.2 Merck KGaA Introduction and Business Overview
10.3.3 Merck KGaA PD-L1 Inhibitors Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Merck KGaA PD-L1 Inhibitors Products Offered
10.3.5 Merck KGaA Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 PD-L1 Inhibitors Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 PD-L1 Inhibitors Industrial Chain Analysis
11.4 PD-L1 Inhibitors Market Dynamics
11.4.1 PD-L1 Inhibitors Industry Trends
11.4.2 PD-L1 Inhibitors Market Drivers
11.4.3 PD-L1 Inhibitors Market Challenges
11.4.4 PD-L1 Inhibitors Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 PD-L1 Inhibitors Distributors
12.3 PD-L1 Inhibitors Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of TECENTRIQ
Table 2. Major Company of Imfinzi
Table 3. Major Company of Bavencio
Table 4. Global PD-L1 Inhibitors Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global PD-L1 Inhibitors Sales by Type (2018-2024) & (K Units)
Table 6. Global PD-L1 Inhibitors Sales Market Share in Volume by Type (2018-2024)
Table 7. Global PD-L1 Inhibitors Sales by Type (2018-2024) & (US& Million)
Table 8. Global PD-L1 Inhibitors Market Share in Value by Type (2018-2024)
Table 9. Global PD-L1 Inhibitors Price by Type (2018-2024) & (US$/Unit)
Table 10. Global PD-L1 Inhibitors Sales by Type (2024-2029) & (K Units)
Table 11. Global PD-L1 Inhibitors Sales Market Share in Volume by Type (2024-2029)
Table 12. Global PD-L1 Inhibitors Sales by Type (2024-2029) & (US$ Million)
Table 13. Global PD-L1 Inhibitors Sales Market Share in Value by Type (2024-2029)
Table 14. Global PD-L1 Inhibitors Price by Type (2024-2029) & (US$/Unit)
Table 15. North America PD-L1 Inhibitors Sales by Type (2018-2024) & (K Units)
Table 16. North America PD-L1 Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe PD-L1 Inhibitors Sales (K Units) by Type (2018-2024)
Table 18. Europe PD-L1 Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific PD-L1 Inhibitors Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific PD-L1 Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America PD-L1 Inhibitors Sales (K Units) by Type (2018-2024)
Table 22. Latin America PD-L1 Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa PD-L1 Inhibitors Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa PD-L1 Inhibitors Sales by Type (2018-2024) & (US$ Million)
Table 25. Global PD-L1 Inhibitors Sales by Company (2018-2024) & (K Units)
Table 26. Global PD-L1 Inhibitors Sales Share by Company (2018-2024)
Table 27. Global PD-L1 Inhibitors Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global PD-L1 Inhibitors Revenue Share by Company (2018-2024)
Table 29. Global Market PD-L1 Inhibitors Price by Company (2018-2024) & (US$/Unit)
Table 30. Global PD-L1 Inhibitors Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global PD-L1 Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PD-L1 Inhibitors as of 2022)
Table 33. Date of Key Manufacturers Enter into PD-L1 Inhibitors Market
Table 34. Key Manufacturers PD-L1 Inhibitors Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global PD-L1 Inhibitors Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 37. Global PD-L1 Inhibitors Sales by Region (2018-2024) & (K Units)
Table 38. Global PD-L1 Inhibitors Sales Market Share in Volume by Region (2018-2024)
Table 39. Global PD-L1 Inhibitors Sales by Region (2018-2024) & (US$ Million)
Table 40. Global PD-L1 Inhibitors Sales Market Share in Value by Region (2018-2024)
Table 41. Global PD-L1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 42. Global PD-L1 Inhibitors Sales by Region (2024-2029) & (K Units)
Table 43. Global PD-L1 Inhibitors Sales Market Share in Volume by Region (2024-2029)
Table 44. Global PD-L1 Inhibitors Sales by Region (2024-2029) & (US$ Million)
Table 45. Global PD-L1 Inhibitors Sales Market Share in Value by Region (2024-2029)
Table 46. Global PD-L1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 47. Global PD-L1 Inhibitors Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 48. Global PD-L1 Inhibitors Sales by Application (2018-2024) & (K Units)
Table 49. Global PD-L1 Inhibitors Sales Market Share in Volume by Application (2018-2024)
Table 50. Global PD-L1 Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 51. Global PD-L1 Inhibitors Sales Market Share in Value by Application (2018-2024)
Table 52. Global PD-L1 Inhibitors Price by Application (2018-2024) & (US$/Unit)
Table 53. Global PD-L1 Inhibitors Sales by Application (2024-2029) & (K Units)
Table 54. Global PD-L1 Inhibitors Sales Market Share in Volume by Application (2024-2029)
Table 55. Global PD-L1 Inhibitors Sales by Application (2024-2029) & (US$ Million)
Table 56. Global PD-L1 Inhibitors Sales Market Share in Value by Application (2024-2029)
Table 57. Global PD-L1 Inhibitors Price by Application (2024-2029) & (US$/Unit)
Table 58. North America PD-L1 Inhibitors Sales by Application (2018-2024) (K Units)
Table 59. North America PD-L1 Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe PD-L1 Inhibitors Sales by Application (2018-2024) (K Units)
Table 61. Europe PD-L1 Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific PD-L1 Inhibitors Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific PD-L1 Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America PD-L1 Inhibitors Sales by Application (2018-2024) (K Units)
Table 65. Latin America PD-L1 Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa PD-L1 Inhibitors Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa PD-L1 Inhibitors Sales by Application (2018-2024) & (US$ Million)
Table 68. North America PD-L1 Inhibitors Sales by Country (2018-2024) & (K Units)
Table 69. North America PD-L1 Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 70. North America PD-L1 Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 71. North America PD-L1 Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 72. North America PD-L1 Inhibitors Sales by Country (2024-2029) & (K Units)
Table 73. North America PD-L1 Inhibitors Sales Market Share in Volume by Country (2024-2029)
Table 74. North America PD-L1 Inhibitors Sales by Country (2024-2029) & (US$ Million)
Table 75. North America PD-L1 Inhibitors Sales Market Share in Value by Country (2024-2029)
Table 76. Europe PD-L1 Inhibitors Sales by Country (2018-2024) & (K Units)
Table 77. Europe PD-L1 Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe PD-L1 Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe PD-L1 Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 80. Europe PD-L1 Inhibitors Sales by Country (2024-2029) & (K Units)
Table 81. Europe PD-L1 Inhibitors Sales Market Share in Volume by Country (2024-2029)
Table 82. Europe PD-L1 Inhibitors Sales by Country (2024-2029) & (US$ Million)
Table 83. Europe PD-L1 Inhibitors Sales Market Share in Value by Country (2024-2029)
Table 84. Asia-Pacific PD-L1 Inhibitors Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific PD-L1 Inhibitors Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific PD-L1 Inhibitors Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific PD-L1 Inhibitors Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific PD-L1 Inhibitors Sales by Region (2024-2029) & (K Units)
Table 89. Asia-Pacific PD-L1 Inhibitors Sales Market Share in Volume by Region (2024-2029)
Table 90. Asia-Pacific PD-L1 Inhibitors Sales by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific PD-L1 Inhibitors Sales Market Share in Value by Region (2024-2029)
Table 92. Latin America PD-L1 Inhibitors Sales by Country (2018-2024) & (K Units)
Table 93. Latin America PD-L1 Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America PD-L1 Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America PD-L1 Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America PD-L1 Inhibitors Sales by Country (2024-2029) & (K Units)
Table 97. Latin America PD-L1 Inhibitors Sales Market Share in Volume by Country (2024-2029)
Table 98. Latin America PD-L1 Inhibitors Sales by Country (2024-2029) & (US$ Million)
Table 99. Latin America PD-L1 Inhibitors Sales Market Share in Value by Country (2024-2029)
Table 100. Middle East and Africa PD-L1 Inhibitors Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa PD-L1 Inhibitors Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa PD-L1 Inhibitors Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa PD-L1 Inhibitors Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa PD-L1 Inhibitors Sales by Country (2024-2029) & (K Units)
Table 105. Middle East and Africa PD-L1 Inhibitors Sales Market Share in Volume by Country (2024-2029)
Table 106. Middle East and Africa PD-L1 Inhibitors Sales by Country (2024-2029) & (US$ Million)
Table 107. Middle East and Africa PD-L1 Inhibitors Sales Market Share in Value by Country (2024-2029)
Table 108. Roche Company Information
Table 109. Roche Introduction and Business Overview
Table 110. Roche PD-L1 Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Roche PD-L1 Inhibitors Product
Table 112. Roche Recent Development
Table 113. AstraZeneca Company Information
Table 114. AstraZeneca Introduction and Business Overview
Table 115. AstraZeneca PD-L1 Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. AstraZeneca PD-L1 Inhibitors Product
Table 117. AstraZeneca Recent Development
Table 118. Merck KGaA Company Information
Table 119. Merck KGaA Introduction and Business Overview
Table 120. Merck KGaA PD-L1 Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Merck KGaA PD-L1 Inhibitors Product
Table 122. Merck KGaA Recent Development
Table 123. Key Raw Materials Lists
Table 124. Raw Materials Key Suppliers Lists
Table 125. PD-L1 Inhibitors Market Trends
Table 126. PD-L1 Inhibitors Market Drivers
Table 127. PD-L1 Inhibitors Market Challenges
Table 128. PD-L1 Inhibitors Market Restraints
Table 129. PD-L1 Inhibitors Distributors List
Table 130. PD-L1 Inhibitors Downstream Customers
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. PD-L1 Inhibitors Product Picture
Figure 2. Global PD-L1 Inhibitors Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global PD-L1 Inhibitors Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global PD-L1 Inhibitors Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of TECENTRIQ
Figure 6. Global TECENTRIQ Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Imfinzi
Figure 8. Global Imfinzi Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Bavencio
Figure 10. Global Bavencio Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Global PD-L1 Inhibitors Sales by Type (2018-2029) & (US$ Million)
Figure 12. Global PD-L1 Inhibitors Sales Market Share by Type in 2022 & 2029
Figure 13. North America PD-L1 Inhibitors Sales Market Share in Volume by Type in 2022
Figure 14. North America PD-L1 Inhibitors Sales Market Share in Value by Type in 2022
Figure 15. Europe PD-L1 Inhibitors Sales Market Share in Volume by Type in 2022
Figure 16. Europe PD-L1 Inhibitors Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific PD-L1 Inhibitors Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific PD-L1 Inhibitors Sales Market Share in Value by Type in 2022
Figure 19. Latin America PD-L1 Inhibitors Sales Market Share in Volume by Type in 2022
Figure 20. Latin America PD-L1 Inhibitors Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa PD-L1 Inhibitors Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa PD-L1 Inhibitors Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by PD-L1 Inhibitors Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by PD-L1 Inhibitors Revenue in 2022
Figure 25. PD-L1 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Retail Pharmacy
Figure 27. Global Retail Pharmacy Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Hospital Pharmacy
Figure 29. Global Hospital Pharmacy Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Other
Figure 31. Global Other Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Global PD-L1 Inhibitors Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global PD-L1 Inhibitors Sales Market Share by Application in 2022 & 2029
Figure 34. North America PD-L1 Inhibitors Sales Market Share in Volume by Application in 2022
Figure 35. North America PD-L1 Inhibitors Sales Market Share in Value by Application in 2022
Figure 36. Europe PD-L1 Inhibitors Sales Market Share in Volume by Application in 2022
Figure 37. Europe PD-L1 Inhibitors Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific PD-L1 Inhibitors Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific PD-L1 Inhibitors Sales Market Share in Value by Application in 2022
Figure 40. Latin America PD-L1 Inhibitors Sales Market Share in Volume by Application in 2022
Figure 41. Latin America PD-L1 Inhibitors Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa PD-L1 Inhibitors Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. PD-L1 Inhibitors Manufacturing Cost Structure
Figure 45. PD-L1 Inhibitors Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries